# Study of Adalimumab or Placebo in Patients With Mild to Moderate COVID-19 (COMBAAT)

> **NCT04705844** · PHASE3 · WITHDRAWN · sponsor: **Alachua Government Services, Inc.**

## Conditions studied

- Mild to Moderate COVID-19

## Interventions

- **DRUG:** Adalimumab
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT04705844
- **Lead sponsor:** Alachua Government Services, Inc.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** WITHDRAWN
- **Start date:** 2021-09
- **Primary completion:** 2022-09
- **Final completion:** 2022-09
- **Target enrollment:** 0 (ACTUAL)
- **Why stopped:** study withdrawn prior to screening subjects
- **Last updated:** 2022-03-03

## Collaborators

- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04705844

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04705844, "Study of Adalimumab or Placebo in Patients With Mild to Moderate COVID-19 (COMBAAT)". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT04705844. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*